X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10438) 10438
Book Review (3396) 3396
Publication (1018) 1018
Conference Proceeding (22) 22
Book Chapter (20) 20
Dissertation (9) 9
Magazine Article (4) 4
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8366) 8366
humans (7660) 7660
oncology (6768) 6768
1st-line treatment (6635) 6635
female (4501) 4501
chemotherapy (4469) 4469
middle aged (3387) 3387
male (3381) 3381
aged (3349) 3349
cancer (2971) 2971
adult (2629) 2629
antineoplastic combined chemotherapy protocols - therapeutic use (2543) 2543
treatment outcome (2425) 2425
open-label (2329) 2329
1st-line therapy (1935) 1935
care and treatment (1815) 1815
colorectal cancer (1700) 1700
antineoplastic agents - therapeutic use (1652) 1652
metastasis (1609) 1609
colorectal neoplasms - drug therapy (1446) 1446
aged, 80 and over (1423) 1423
phase-iii trial (1403) 1403
fluorouracil (1391) 1391
disease-free survival (1378) 1378
bevacizumab (1361) 1361
oxaliplatin (1311) 1311
lung neoplasms - drug therapy (1301) 1301
pharmacology & pharmacy (1296) 1296
survival (1276) 1276
mutation (1209) 1209
prognosis (1198) 1198
research (1173) 1173
antineoplastic combined chemotherapy protocols - adverse effects (1169) 1169
colorectal neoplasms - pathology (1150) 1150
therapy (1120) 1120
carcinoma, non-small-cell lung - drug therapy (1097) 1097
analysis (1078) 1078
phase-ii trial (1077) 1077
drug therapy (1075) 1075
trial (1072) 1072
double-blind (1057) 1057
medicine & public health (1049) 1049
neoplasm metastasis (1016) 1016
leucovorin (999) 999
phase-iii (987) 987
clinical trials (966) 966
neoplasm staging (966) 966
breast cancer (946) 946
lung cancer (924) 924
hematology, oncology and palliative medicine (915) 915
randomized-trial (907) 907
breast neoplasms - drug therapy (895) 895
combination (887) 887
retrospective studies (885) 885
multicenter (883) 883
cancer therapies (876) 876
health aspects (862) 862
1st-line chemotherapy (833) 833
gefitinib (827) 827
cetuximab (824) 824
patients (815) 815
cell lung-cancer (806) 806
survival analysis (801) 801
irinotecan (798) 798
erlotinib (797) 797
fluorouracil - administration & dosage (796) 796
lung cancer, non-small cell (783) 783
capecitabine (779) 779
growth-factor receptor (775) 775
cisplatin (774) 774
phase-ii (747) 747
metastatic colorectal-cancer (744) 744
survival rate (726) 726
hematology (715) 715
antineoplastic combined chemotherapy protocols - administration & dosage (713) 713
tumors (712) 712
lung neoplasms - pathology (707) 707
deoxycytidine - analogs & derivatives (688) 688
paclitaxel (685) 685
surgery (665) 665
animals (658) 658
docetaxel (654) 654
adenocarcinoma (651) 651
lung neoplasms - genetics (648) 648
epidermal growth factor (647) 647
antineoplastic agents (641) 641
efficacy (623) 623
organoplatinum compounds - administration & dosage (610) 610
camptothecin - analogs & derivatives (608) 608
protein kinase inhibitors - therapeutic use (603) 603
antimitotic agents (596) 596
randomized controlled trials as topic (595) 595
carcinoma, non-small-cell lung - pathology (583) 583
non-small cell lung cancer (581) 581
antibodies, monoclonal - therapeutic use (561) 561
drug administration schedule (553) 553
respiratory system (553) 553
genetic aspects (551) 551
review (547) 547
antineoplastic agents - adverse effects (546) 546
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10183) 10183
German (111) 111
French (92) 92
Spanish (20) 20
Polish (10) 10
Russian (9) 9
Italian (6) 6
Korean (5) 5
Portuguese (5) 5
Hungarian (4) 4
Japanese (3) 3
Chinese (1) 1
Czech (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Clinical Oncology, ISSN 1759-4774, 10/2013, Volume 10, Issue 10, pp. 551 - 552
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 247 - 255
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2008, Volume 26, Issue 32, pp. 5156 - 5164
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 08/2017, Volume 17, Issue 1, pp. 548 - 548
Background: Metastatic colorectal cancer (mCRC) is a disease of older age, but there is a relative lack of knowledge about effects of chemotherapy in older... 
IRIS | Geriatric assessment | Randomized phase II | Oral | SOX | Metastatic colorectal cancer | Non-intensive | 1ST-LINE TREATMENT | YOUNGER PATIENTS | INTERNATIONAL-SOCIETY | OPEN-LABEL | ONCOLOGY | SCREENING TOOLS | PHASE-3 TRIAL | ELDERLY-PATIENTS | COOPERATIVE-ONCOLOGY-GROUP | PALLIATIVE CHEMOTHERAPY | Geriatric Assessment | Age Factors | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Colorectal Neoplasms - drug therapy | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Camptothecin - therapeutic use | Tegafur - adverse effects | Tegafur - therapeutic use | Oxonic Acid - administration & dosage | Oxonic Acid - adverse effects | Oxonic Acid - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Colorectal Neoplasms - pathology | Neoplasm Staging | Research Design | Drug Combinations | Antimitotic agents | Care and treatment | Cancer patients | Chemotherapy | Colorectal cancer | Clinical trials | Aged patients | Metastasis | Drug therapy, Combination | Antineoplastic agents | Cancer | Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | Cancer and Oncology | Cancer och onkologi
Journal Article
Cancer, ISSN 0008-543X, 11/2013, Volume 119, Issue 21, pp. 3761 - 3768
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 03/2016, Volume 111, Issue 3, pp. 381 - 387
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INFUSIONAL FLUOROURACIL | LEUCOVORIN | MANAGEMENT | PHASE-III | GUIDELINES | IRINOTECAN | OXALIPLATIN | CHEMOTHERAPY | FOLFIRI | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 4/2015, Volume 20, Issue 2, pp. 207 - 239
Journal Article